Interventional Study on Pentostatin, Cyclophosphamide and Rituximab in Indolent B-Cell Non-Hodgkin-Lymphoma (B-NHL) - Related Studies

Interventional Study on Pentostatin, Cyclophosphamide and Rituximab in Indolent B-Cell Non-Hodgkin-Lymphoma (B-NHL) (PERLL)

The recruitment status of this study is unknown because the information has not been verified recently.

Verified June 2009 by University of Heidelberg.
Recruitment status was Active, not recruiting

Study NCT00927797 Information provided by University of Heidelberg

First Received on June 23, 2009. Last Updated on June 24, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

More general conditions related to this trial

Additional drug interventions recognized in this trial

Cyclophosphamide
Pentostatin
Rituximab

More general drug interventions related to this trial

Sponsors listed in this trial